Repare Therapeutics Statistics
Total Valuation
RPTX has a market cap or net worth of $43.15 million. The enterprise value is -$107.50 million.
Important Dates
The last earnings date was Monday, March 3, 2025, before market open.
Earnings Date | Mar 3, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
RPTX has 42.51 million shares outstanding. The number of shares has increased by 0.76% in one year.
Current Share Class | 42.51M |
Shares Outstanding | 42.51M |
Shares Change (YoY) | +0.76% |
Shares Change (QoQ) | +0.14% |
Owned by Insiders (%) | 1.08% |
Owned by Institutions (%) | 31.20% |
Float | 22.31M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.83 |
Forward PS | 5.99 |
PB Ratio | 0.30 |
P/TBV Ratio | 0.29 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.77, with a Debt / Equity ratio of 0.01.
Current Ratio | 6.77 |
Quick Ratio | 6.53 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -46.63% and return on invested capital (ROIC) is -31.25%.
Return on Equity (ROE) | -46.63% |
Return on Assets (ROA) | -26.76% |
Return on Invested Capital (ROIC) | -31.25% |
Return on Capital Employed (ROCE) | -60.93% |
Revenue Per Employee | $414,550 |
Profits Per Employee | -$656,504 |
Employee Count | 129 |
Asset Turnover | 0.25 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, RPTX has paid $1.44 million in taxes.
Income Tax | 1.44M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -77.52% in the last 52 weeks. The beta is 0.87, so RPTX's price volatility has been lower than the market average.
Beta (5Y) | 0.87 |
52-Week Price Change | -77.52% |
50-Day Moving Average | 1.19 |
200-Day Moving Average | 2.60 |
Relative Strength Index (RSI) | 36.94 |
Average Volume (20 Days) | 221,902 |
Short Selling Information
The latest short interest is 1.00 million, so 2.36% of the outstanding shares have been sold short.
Short Interest | 1.00M |
Short Previous Month | 1.06M |
Short % of Shares Out | 2.36% |
Short % of Float | 4.49% |
Short Ratio (days to cover) | 5.22 |
Income Statement
In the last 12 months, RPTX had revenue of $53.48 million and -$84.69 million in losses. Loss per share was -$2.00.
Revenue | 53.48M |
Gross Profit | 40.10M |
Operating Income | -92.14M |
Pretax Income | -83.68M |
Net Income | -84.69M |
EBITDA | -90.22M |
EBIT | -92.14M |
Loss Per Share | -$2.00 |
Full Income Statement Balance Sheet
The company has $152.79 million in cash and $1.93 million in debt, giving a net cash position of $150.86 million or $3.55 per share.
Cash & Cash Equivalents | 152.79M |
Total Debt | 1.93M |
Net Cash | 150.86M |
Net Cash Per Share | $3.55 |
Equity (Book Value) | 151.13M |
Book Value Per Share | 3.56 |
Working Capital | 145.86M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -76.45M |
Capital Expenditures | n/a |
Free Cash Flow | -76.45M |
FCF Per Share | -$1.80 |
Full Cash Flow Statement Margins
Gross margin is 74.98%, with operating and profit margins of -172.31% and -158.37%.
Gross Margin | 74.98% |
Operating Margin | -172.31% |
Pretax Margin | -155.67% |
Profit Margin | -158.37% |
EBITDA Margin | -168.71% |
EBIT Margin | -172.31% |
FCF Margin | n/a |
Dividends & Yields
RPTX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.76% |
Shareholder Yield | -0.76% |
Earnings Yield | -195.31% |
FCF Yield | -176.30% |
Analyst Forecast
The average price target for RPTX is $4.50, which is 343.35% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $4.50 |
Price Target Difference | 343.35% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | -19.33% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
RPTX has an Altman Z-Score of 0.3 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 0.3 |
Piotroski F-Score | 4 |